Eurofins, FR0014000MR3

Eurofins schedules nine-month update: Eurofins stock sits 0.86 percent below its high

Published on 10/20/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eurofins will publish its update on October 21, 2026. Eurofins stock costs EUR 78.54 on October 20, 2026 versus the EUR 78.94 Xetra close.

Reporting dates and operating progress

  • Eurofins will publish a nine-month update on October 21, 2026.
  • First-half results showed 130 basis points of adjusted EBITDA margin expansion and 29 percent EPS growth on July 23, 2026.
  • Eurofins stock trades at EUR 78.54 at 10:08 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.51 percent below the Xetra close of October 19, 2026.
Isometrische 3D-Darstellung der Testprozesskette zeigt die Wertschöpfung von Eurofins Scientific SE, ISIN FR0014000MR3, im Labor, Illustration mit AI erstellt.

Eurofins stock (ISIN FR0014000MR3) was trading at EUR 78.54 at Lang & Schwarz on October 20, 2026 at 10:08 a.m. CEST, down 0.51 percent versus the Xetra close of October 19, 2026 at EUR 78.94. Eurofins will publish its nine-month 2026 trading update on October 21, 2026.

What the next update will test

The upcoming release will give investors a fresh operating check after Eurofins reported progress toward its mid-term objectives in the first half. The company said on July 23, 2026, that adjusted EBITDA margin expanded by 130 basis points and earnings per share grew 29 percent. Those figures make margin delivery and earnings conversion the key benchmarks for the next update, rather than the date alone.

Eurofins also enters the release with a larger North American life-sciences platform. In a release dated October 2, 2026, Eurofins said it had completed the USD 400 million acquisition of Element Materials Technology's North American Life Sciences Testing Services business. The acquired operations include 27 laboratories and facilities, about 750 employees, and expected 2026 revenue of more than USD 150 million.

Three dates define the setup

On July 23, 2026, Eurofins reported 130 basis points of adjusted EBITDA margin expansion and 29 percent earnings-per-share growth for the first half. On October 1, 2026, it completed the USD 400 million Element transaction, according to the company's October 2 release. On October 21, 2026, Eurofins is scheduled to publish its nine-month trading update, making the release the next quantified checkpoint for the stock.

Which dates come next?

The next reporting date is October 21, 2026, for the nine-month trading update. Eurofins also lists an investor day in Amersfoort, Netherlands, for October 23, 2026, followed by a Toronto investor day on November 11, 2026, according to its investor-relations calendar.

Stock remains near its yearly high

At EUR 78.54, the share price was EUR 0.68 below its 52-week high of EUR 79.22, a gap of 0.86 percent. The latest quoted market capitalization was EUR 13.6 billion, while the 52-week range extended down to EUR 54.86. The setup leaves the October 21 update as the next company-specific test for whether recent margin and earnings progress is continuing.

Eurofins stock was trading at EUR 78.54 at Lang & Schwarz on October 20, 2026 at 10:08 a.m. CEST, down 0.51 percent versus the Xetra close of October 19, 2026 at EUR 78.94. The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.

Eurofins stock facts

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: ERF.PA
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz (as of October 20, 2026, 10:08 a.m. CEST): EUR 78.54
  • Change versus Xetra close: minus 0.51 percent
  • Xetra close (October 19, 2026): EUR 78.94
  • Market capitalization: EUR 13.6 billion (as of October 20, 2026)
  • 52-week range: EUR 54.86-EUR 79.22 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report CAC 40.

More news and analyses on Eurofins stock

Disclaimer...
en | FR0014000MR3 | EUROFINS | boerse | 70370533 | bgmi